Emergent BioSolutions Inc.
EBS
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emerging infectious diseases; travel health; and emerging hā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
19 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$12.24
Price-1.13%
-$0.14
1Y
Price
Market Cap
$660.655m
Small
Price/Earnings 3y Avg5y Avg
9.3x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in USD.+41.6%
EBITDA Margin+22.2%
Net Profit Margin-2.5%
Free Cash Flow Margin+41.6%
EBITDA Margin+22.2%
Net Profit Margin-2.5%
Free Cash Flow MarginRevenue
$788.900m
-24.4%
1y CAGR-10.3%
3y CAGR-17.0%
5y CAGREarnings
$75.900m
+139.8%
1y CAGR-14.9%
3y CAGR-60.3%
5y CAGREPS
$1.29
+135.8%
1y CAGR-6.9%
3y CAGR-57.7%
5y CAGRBook Value
$582.500m
$1.461b
Assets$878.500m
Liabilities$663.100m
DebtDebt to Assets
45.4%
3.1x
Debt to EBITDAFree Cash Flow
$1.400m
-96.1%
1y CAGR-18.1%
3y CAGR-77.6%
5y CAGRNo items found.
Press Releases
Statements and updates from the company